Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05547321
Title Efficacy and Safety Study of OMTX705, Monotherapy and Pembrolizumab-combined, in Subjects With Advanced Solid Tumors.
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Oncomatryx Biopharma S.L.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | ESP

Facility Status City State Zip Country Details
Beth Israel Deaconess Medical Center RECRUITING Boston Massachusetts 02215 United States Details
ICO L'Hospitalet RECRUITING L'Hospitalet de Llobregat Barcelona Spain Details
Hospital Universitario de Donostia RECRUITING San Sebastián Guipúzcoa Spain Details
Clínica Universitaria de Navarra RECRUITING Pamplona Navarra Spain Details
Hospital Universitari Vall d'Hebron NOT_YET_RECRUITING Barcelona Spain Details
Hospital 12 Octubre RECRUITING Madrid Spain Details
Hospital MD Anderson RECRUITING Madrid Spain Details
Onkologikoa RECRUITING San Sebastián Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field